Highly Variable Drug Comparison

Highly Variable Drug Comparison is a reference product comparison method that specifically addresses the bioequivalence assessment of highly variable drugs by employing scaled average bioequivalence or adaptive statistical approaches to account for intra-subject variability exceeding conventional thresholds.

11

Publications

384

Citations

33

Authors

18

Institutions

Publications per year

2017–2026

2

Authors

33

  1. KH
    Kate Howland

    New Frontier, United States

    1 publications · 39 citations

    1

    h-index

  2. EY
    Eun Young Bae

    Korea Research Institute of Bioscience and Biotechnology, South Korea

    1 publications · 19 citations

    1

    h-index

  3. TH
    Timothy H. Montague

    GlaxoSmithKline (United States), United States

    1 publications · 39 citations

    1

    h-index

  4. MK
    Meinhard Kieser

    Heidelberg University, Germany

    1 publications · 10 citations

    1

    h-index

  5. KD
    Karlheinz Doser

    Hella (Germany), Germany

    1 publications · 10 citations

    1

    h-index

1–5 of 33

Venues

  1. European Journal of Clinical Pharmacology

    2 publications · 49 citations

    2

    h-index

  2. PubMed

    Repository · 2 publications · 31 citations

    2

    h-index

  3. European Journal of Pharmaceutical Sciences

    2 publications · 39 citations

    2

    h-index

  4. Statistics in Medicine

    1 publications · 12 citations

    1

    h-index

  5. Health Policy

    1 publications · 19 citations

    1

    h-index

1–5